Project Grant R01AA032786
- The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $880,688 on August 4, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct research imaging glucocorticoid function in women with childhood trauma and alcohol use disorder. The research uses positron emission tomography with a novel radiotracer called [18F]FMOZAT to investigate brain cortisol as a potential biomarker of stress dysregulation in women with childhood trauma and alcohol use disorder. The...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a division of the Department of Health and Human Services National Institutes of Health, awarded Yale University $663,419 on August 11, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate liver sinusoidal endothelial cell (LSEC) inflammation in alcohol-associated liver disease. The research addresses mechanisms by which alcohol disrupts LSEC homeostasis through two converging pathways: IL6 trans-signaling mediated...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded $167,500 in Project Grant funding to the University of Massachusetts Medical School on September 17, 2025, through the Alcohol Research Programs (CFDA 93.273) for a research study investigating sex differences in excessive alcohol use patterns across young adulthood and middle age. The research will utilize longitudinal data from the National Longitudinal Study of Adolescent to Adult Health (Add Health) to examine how...
- The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $671,854 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct neurocomputational and ecological assessments of the mutual influence between alcohol craving and decision-making. The research examines the bidirectional interactions between alcohol craving and maladaptive decision-making in heavy and binge drinkers, with the goal of developing computational models that account for the...
- The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $100,228 under the Alcohol Research Programs (CFDA 93.273) on October 27, 2026, to investigate the neurobiological mechanisms underlying the co-occurrence of alcohol use disorder and post-traumatic stress disorder. The project examines how stress exposure disrupts excitation-inhibition balance in the medial prefrontal cortex, driving increased alcohol consumption and heightened motivation for alcohol use. Using single...
- The National Institute on Alcohol Abuse and Alcoholism awarded Weill Medical College of Cornell University $591,468 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct longitudinal neuroimaging analysis identifying neural risk factors for drinking onset in young adulthood. The recipient will apply machine learning analysis to nine years of longitudinal neuroimaging, behavioral, and neuropsychological data from 466 adolescents (baseline ages 12–18 years) enrolled in...
- The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $576,197 on September 16, 2025, under the Alcohol Research Programs (CFDA 93.273) to develop and test a digital pill system paired with smartphone-delivered cognitive behavioral therapy to measure and support acamprosate adherence in individuals with alcohol use disorder and alcohol-associated liver disease. Yale will develop a user-centered adherence intervention called ACAMPROSYNC that combines a digital pill system...
- The National Institute on Alcohol Abuse and Alcoholism awarded Vanderbilt University $314,616 on January 25, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate cell-type-specific neural mechanisms underlying alcohol-associated behavior in the striatum. The research elucidates how D2-receptor-containing medium spiny neurons in the nucleus accumbens encode associations between alcohol-related cues and outcomes, and how chronic alcohol exposure and abstinence alter these...
- The National Institute on Alcohol Abuse and Alcoholism awarded Trustees of Tufts College $686,774 on July 20, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct behavioral neurobiology research on stress, alcohol responsivity, and alcohol drinking patterns. The research uses rodent models to investigate how stress exposure alters sensitivity to alcohol's aversive effects and the neural circuits involved. The study employs classical and operant conditioning paradigms combined with...
- The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $1,649,143 on August 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct psychometric evaluation of the Yale Alcohol Craving Scale, a patient-reported outcome measure for assessing alcohol craving severity. Yale will develop and validate the YACS by administering an online survey to 1,500 adults recruited from online panels, community settings, and treatment programs to ensure representation across...
The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $713,580 on August 6, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct imaging research on sex differences in the cortical reward system of people with alcohol use disorder. The research examines dopamine neurotransmission in the mesocortical pathway—which regulates executive functions, reward sensitivity, stress response, and cognitive function—comparing men and women with alcohol use disorder. The project focuses on cortical dopamine systems using imaging methods capable of detecting dopamine in critical cortical brain regions, addressing a gap in existing literature that has primarily studied the mesolimbic pathway (reward center) and relied on radiotracers unable to detect dopamine in cortical areas. The research responds to evidence that women with alcohol use disorder experience greater vulnerability to reward and stress sensitivity, cognitive dysfunction, and poorer treatment outcomes than men, with dopamine system dysfunction implicated in both disorder development and maintenance. Performance occurs in New Haven, Connecticut, with a period of performance extending through April 30, 2031. The assistance type is a Project Grant, a standard NIH research grant mechanism typically supporting projects over up to five years. Yale University serves as the recipient institution.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $713.6k | 8/10/26 |